Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|March 13, 2025
αKG-induced oxidative stress and mTOR inhibition as a therapeutic strategy for liver cancerSung Kyung Choi, Myoung Jun Kim, Jueng Soo You
International Journal of Molecular Sciences|June 5, 2020
SMARCB1 Acts as a Quiescent Gatekeeper for Cell Cycle and Immune Response in Human CellsSung Kyung Choi, Myoung Jun Kim, Jueng Soo You
Biochemical and Biophysical Research Communications|April 6, 2024
Mdivi-1: Effective but complex mitochondrial fission inhibitorSeor I Ahn, Sung Kyung Choi, Myoung Jun Kim, et al.
Biochemical and Biophysical Research Communications|February 4, 2026
USP21-mediated SMARCB1 stabilization under hypoxia may influence tumor progression and immune response in HCCMinho Kim, Myoung Jun Kim, Sung Kyung Choi, et al.
International Journal of Oncology|May 12, 2018
Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1Myoung Jun Kim, Sung Kyung Choi, Seong Hwi Hong, et al.
Neurogenetics|May 6, 2010
Myotonic dystrophy type I combined with X-linked dominant Charcot-Marie-Tooth neuropathyHyun Sook Kim, Ki Wha Chung, Sung Hee Kang, et al.
Oncology Reports|November 18, 2015
JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanismsSung Kyung Choi, Seong Hwi Hong, Hyuk Soon Kim, et al.
Oncotarget|December 13, 2017
Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29Sung Kyung Choi, Kurinji Pandiyan, Jung Woo Eun, et al.
Pageof 2